STOCK TITAN

Xos, Inc. (XOSWW) SEC Filings

XOSWW NASDAQ

Welcome to our dedicated page for Xos SEC filings (Ticker: XOSWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xos's regulatory disclosures and financial reporting.

Rhea-AI Summary

Xos, Inc. (XOS) director Alice Yake filed an amended Form 4 correcting prior transaction codes to show that three transactions in July 2026 were open-market sales (Code "S") of common stock, not dispositions to the issuer. Yake sold a total of 7,500 shares on July 15–17, 2026 under a Rule 10b5-1 trading plan adopted on September 29, 2025, at weighted average prices around $2.15–$2.30 per share. Reported holdings include 60,584 unvested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) reports that director Michael Paul Richardson sold a total of 9,356 shares of Common Stock in three open-market transactions on July 15–17, 2026, at weighted average prices around $2.11–$2.31 per share. The amendment clarifies these trades were Code “S” sales under a Rule 10b5-1 trading plan adopted on September 16, 2025, correcting an earlier miscoding as Code “D”, with no other changes to the original report. Post-transaction holdings include 60,584 unvested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) discloses an amended insider trading report for director Dietmar Ostermann. The amendment corrects prior transaction codes, clarifying that three July 2026 transactions were open-market sales (Code "S") rather than dispositions coded as "D". No other details from the original Form 4 are changed.

The director sold 4,159 shares of common stock on July 15, 2026 at a weighted average price of $2.3025 per share, 4,158 shares on July 16, 2026 at a weighted average of $2.1607, and 4,159 shares on July 17, 2026 at a weighted average of $2.1485. In total, 12,476 shares were sold pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2025. A related footnote states the director’s holdings include 60,584 unvested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Xos, Inc. (XOS) reports an amended Form 4 for director Michael Paul Richardson, correcting prior transaction codes to reflect open‑market sales rather than dispositions to the issuer. On July 10, 13, and 14, 2026, he sold 3,119 shares of common stock on each date under a Rule 10b5-1 trading plan at weighted average prices around $2.35–$2.49 per share. On July 10, 2026, he also received a grant of 60,584 Restricted Stock Units (RSUs), which vest on the earlier of the first anniversary of the grant date or the day before Xos, Inc.'s 2027 annual meeting, subject to continued service. The amendment states no other information changes from the original Form 4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann filed an amended Form 4 to correct prior coding of certain transactions from disposition code "D" to sale code "S". The filing reports a grant of 60,584 RSUs on July 10, 2026 and open-market sales totaling 12,475 shares of common stock on July 10, 13, and 14, 2026, all effected under a Rule 10b5-1 trading plan adopted on September 16, 2025. The RSUs vest on the earlier of the first anniversary of the grant date or the day before Xos, Inc.'s 2027 annual meeting, subject to Ostermann's continuous service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) reports an amended Form 4 for director Alice Yake, correcting prior transaction codes to reflect that certain dispositions were open‑market sales under a Rule 10b5-1 trading plan. On July 10, 2026 she received 60,584 RSUs subject to future vesting and 2,292 immediately vested RSUs in lieu of cash fees. She then sold 2,500 common shares on each of July 10, 13, and 14, 2026 at weighted average prices of $2.4916, $2.3483, and $2.3948 per share, respectively. The amendment states no other information from the original Form 4 has changed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Xos, Inc. (symbol: XOS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) reported an insider transaction by Chief Operating Officer and director Giordano Sordoni. On 2026-08-20, he executed an open-market sale of 49,370 shares of Common Stock at a weighted average price of $4.0014 per share, with individual sale prices ranging from $4.00 to $4.03. Following this transaction, he directly holds 1,553,458 shares of Common Stock, which include 412,242 unvested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann reported a sale of 10,000 shares of common stock on 2026-08-20 in an open-market or private transaction. The weighted average sale price was about $3.49 per share, with prices ranging from $3.49 to $3.50. Following this transaction, he directly holds 105,226 shares, which include 60,584 unvested RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Xos, Inc. (XOS) director Stuart N. Bernstein reported selling 30,000 shares of Common Stock on 2026-08-18 in an open market or private transaction. The weighted average sale price was $4.1945 per share, with individual sales prices ranging from $4.125 to $4.39.

After this sale, Bernstein holds 112,642 shares directly, which include 60,584 unvested RSUs, and 4,133 shares indirectly through Bernstein Investment Partners LLC, where he is the Managing Member. The filing’s Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Xos (XOSWW) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for Xos (XOSWW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Xos (XOSWW)?

The most recent SEC filing for Xos (XOSWW) was filed on August 27, 2026.